Receptor Pharmacology

Advances in Pharmacology

Volumn 52, Issue , 2005, Pages 47-65

  Young, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AC 187; AMYLIN RECEPTOR; CALCITONIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CALCITONIN RECEPTOR-LIKE RECEPTOR; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN; SIGNAL PEPTIDE;

ANIMAL; BINDING COMPETITION; COMPARATIVE STUDY; DRUG ANTAGONISM; HUMAN; METABOLISM; REVIEW;

ANIMALS; BINDING, COMPETITIVE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, CALCITONIN; RECEPTORS, PEPTIDE;

EID: 33645221141     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)52003-9     Document Type: Review

References (62)

1. Aiyar N., Baker E., Martin J., Patel A., Stadel J.M., Willette R.N., and Barone F.C. Differential calcitonin gene-related peptide (CGRP) and amylin binding sites in nucleus accumbens and lung: Potential models for studying CGRP/amylin receptor subtypes. J. Neurochem. 65 (1995) 1131-1138
2. Alam A.S.M., Moonga B.S., Bevis P.J.R., Huang C.L.H., and Zaidi M. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp. Physiol. 78 (1993) 183-196
3. Alam A.S.M.T., Bax C.M.R., Shankar V.S., Bax B.E., Bevis P.J.R., Huang C.L.H., Moonga B.S., Pazianas M., and Zaidi M. Further studies on the mode of action of calcitonin on isolated rat osteoclasts-pharmacological evidence for a 2nd site mediating intracellular Ca2+ mobilization and cell retraction. J. Endocrinol. 136 (1993) 7-15
4. Albrandt K., Mull E., Brady E.M.G., Herich J., Moore C.X., and Beaumont K. Molecular cloning of 2 receptors from rat brain with high affinity for salmon-calcitonin. FEBS Lett. 325 (1993) 225-232
5. Albrandt K., Brady E.M.G., Moore C.X., Mull E., Sierzega M.E., and Beaumont K. Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene. Endocrinology 136 (1995) 5377-5384
6. Barth S.W., Riediger T., Lutz T.A., and Rechkemmer G. Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat. Brain Res. 997 (2004) 97-102
7. Beaumont K., and Rink T.J. Receptor-based screening methods for amylin agonists and antagonists. U.S. Patent 5 (1993) 263-372
8. Beaumont K., and Rink T.J. Receptor-based screening methods for amylin agonists and antagonists. European Patent EP0529065 (1993)
9. Beaumont K., Kenney M.A., Young A.A., and Rink T.J. High affinity amylin binding sites in rat brain. Mol. Pharmacol. 44 (1993) 493-497
10. Beaumont K., Moore C.X., Pittner R.A., Prickett K.S., Gaeta L.S.L., Rink T.J., and Young A.A. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists. Can. J. Physiol. Pharmacol. 73 (1995) 1025-1029
11. Beaumont K., Pittner R.A., Herich J., Albrandt K., and Moore C.X. Coupling of two cloned rat calcitonin receptor isoforms to adenylyl cyclase and phospholipase C. Program and Abstracts, Endocrine Society 76th Annual Meeting, June 15-18, Anaheim, CA (1994) 424
12. Beaumont K., Pittner R.A., Moore C.X., Wolfe-Lopez D., Prickett K.S., Young A.A., and Rink T.J. Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved. Br. J. Pharmacol. 115 (1995) 713-715
13. Brain S.D., Wimalawansa S., MacIntyre I., and Williams T.J. The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. Am. J. Pathol. 136 (1990) 487-490
14. Cao Z.M., Wookey P.J., Wu L.L., Voskuil M., vanGeenen R.C.I., and Cooper M.E. Renal amylin binding in normotensive and hypertensive rats: Effects of angiotensin converting enzyme inhibition with perindopril. J. Hypertension 15 (1997) 1245-1252
15. Chen W.J., Armour S., Way J., Chen G., Watson C., Irving P., Cobb J., Kadwell S., Beaumont K., Rimele T., and Kenakin T. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors. Mol. Pharmacol. 52 (1997) 1164-1175
16. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukase M., Noda T., and Fujita T. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 256 (1989) E331-E335
17. Chin S.Y., Hall J.M., Brain S.D., and Morton I.K.M. Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP (1) receptors. J. Pharmacol. Exp. Ther. 269 (1994) 989-992
18. Christopoulos A., Christopoulos G., Morfis M., Udawela M., Laburthe M., Couvineau A., Kuwasako K., Tilakaratne N., and Sexton P.M. Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278 (2003) 3293-3297
19. Christopoulos G., Paxinos G., Huang X.F., Beaumont K., Toga A.W., and Sexton P.M. Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can. J. Physiol. Pharmacol. 73 (1995) 1037-1041
20. Christopoulos G., Perry K.J., Morfis M., Tilakaratne N., Gao Y., Fraser N.J., Main M.J., Foord S.M., and Sexton P. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56 (1999) 235-242
21. Cooper G.J.S., Rink T.J., and Young A.A. Identifying cpds. which affect amylin activity-using an in-vivo biological model in which amylin increases levels of lactate and glucose. World Patent Application (1992)
22. Deems R.O., Cardinaux F., Deacon R.W., and Young D.A. Amylin or CGRP (8-37) fragments reverse amylin-induced inhibition of 14C-glycogen accumulation. Biochem. Biophys. Res. Commun. 181 (1991) 116-120
23. Edbrooke M.R., Parker D., McVey J.H., Riley J.H., Sorenson G.D., Pettengill O.S., and Craig R.K. Expression of the human calcitonin/CGRP gene in lung and thyroid. EMBO J. 4 (1985) 715-724
24. Gedulin B.R., Jodka C.M., Green D.L., and Young A.A. Comparison of 21 peptides on inhibition of gastric emptying in conscious rats. Dig Dis. Week (1996) A742
25. Goldring S.R., Gorn A.H., Yamin M., Krane S.M., and Wang J.T. Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs. Horm. Metab. Res. 25 (1993) 477-480
26. Gorn A.H., Flannery M.S., Manning C.A., and Goldring S.R. Expression of a cloned high affinity calcitonin (CT) receptor cDNA confers binding and cAMP responsiveness for amylin (AMY) and calcitonin gene related peptide (CGRP). Clin. Res. 40 (1992) 209A
27. Hall J.M., Siney L., Lippton H., Hyman A., Jaw K.C., and Brain S.D. Interaction of human adrenomedullin (13-52) with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. J. Br. J. Pharmacol. 114 (1995) 592-597
28. Han Z.Q., Coppock H.A., Smith D.M., VanNoorden S., Makgoba M.W., Nicholl C.G., and Legon S. The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J. Mol. Endocrinol. 18 (1997) 267-272
29. Hanna F.W.F., Smith D.M., Johnston C.F., Akinsanya K.O., Jackson M.L., Morgan D.G.A., Bhogal R., Buchanan K.D., and Bloom S.R. Expression of a novel receptor for the calcitonin peptide family and a salmon calcitonin-like peptide in the alpha-thyrotropin thyrotroph cell line. Endocrinology 136 (1995) 2377-2382
30. Hay D.L., Christopoulos G., Christopoulos A., and Sexton P.M. Amylin receptors: Molecular composition and pharmacology. Biochem. Soc. Trans. 32 (2004) 865-867
31. Haynes J.M., Wookey P.J., Tikellis C.M., Du H.C., Sexton P.M., and Cooper M.E. Amylin and calcitonin gene related peptide in the rat kidney: Functional and autoradiographic studies. Can. J. Physiol. Pharmacol. 72 (1994) 566
32. Howitt S.G., and Poyner D.R. The selectivity and structural determinants of peptide antagonists at the CGRP receptor of rat, L6 myocytes. J. Br. J. Pharmacol. 121 (1997) 1000-1004
33. Janssen P.L., and Tucker A. Calcitonin gene-related peptide modulates pulmonary vascular reactivity in isolated rat lungs. J. Appl. Physiol. 77 (1994) 142-146
34. Kikumoto K., Katafuchi T., and Minamino N. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins. Hypertens. Res. 26 Suppl. (2003) S15-S23
35. Kuwasako K., Kitamura K., Nagoshi Y., and Eto T. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins. Biochem. Biophys. Res. Commun. 301 (2003) 460-464
36. Lin H.Y., Harris T.L., Flannery M.S., Aruffo A., Kaji E.H., Gorn A., Kolakowski Jr. L.F., Lodish H.F., and Goldring S.R. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254 (1991) 1022-1024
37. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., and Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
38. Muff R., Bühlmann N., Fischer J.A., and Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 140 (1999) 2924-2927
39. Njuki F., Nicholl C.G., Howard A., Mak J.C.W., Barnes P.J., Girgis S.I., and Legon S. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin. Sci. 85 (1993) 385-388
40. Oliver K.R., Kane S.A., Salvatore C.A., Mallee J.J., Kinsey A.M., Koblan K.S., Keyvan-Fouladi N., Heavens R.P., Wainwright A., Jacobson M., Dickerson I.M., and Hill R.G. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur. J. Neurosci. 14 (2001) 618-628
41. Parsons G.H., Nichol G.M., Barnes P.J., and Chung K.F. Peptide mediator effects on bronchial blood velocity and lung resistance in conscious sheep. J. Appl. Physiol. 72 (1992) 1118-1122
42. Perry K.J., Quiza M., Myers D.E., Morfis M., Christopoulos G., and Sexton P.M. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line. Endocrinology 138 (1997) 3486-3496
43. Sexton P.M., McKenzie J.S., and Mendelsohn F.A.O. Evidence for a new subclass of calcitonin/calcitonin gene-related peptide binding site in rat brain. Neurochem. Int. 12 (1988) 323-335
44. Sexton P.M., Paxinos G., Kenney M.A., Wookey P.J., and Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62 (1994) 553-567
45. Sexton P.M., Perry K.J., Christopoulos G., Morfis M., and Tilakaratne N. What makes an amylin receptor?. In: Poyner D., Marshall I., and Brain S. (Eds) (2000), Landes Bioscience, Georgetown, TX 79-89
46. Sonea I.M., Bowker R.M., Robinson N.E., and Broadstone R.V. Substance P and calcitonin gene-related peptide-like immunoreactive nerve fibers in lungs from adult equids. Am. J. Vet. Res. 55 (1994) 1066-1074
47. Steiner S., Muff R., Gujer R., Fischer J.A., and Born W. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor. Biochemistry 41 (2002) 11398-11404
48. Stridsberg M., Tjalve H., and Wilander E. Whole-body autoradiography of 123I-labelled islet amyloid polypeptide (IAPP). Accumulation in the lung parenchyma and in the villi of the intestinal mucosa in rats. Acta Oncol. 32 (1993) 155-159
49. Tilakaratne N., Christopoulos G., Perry K., Morfis M., Foord S.M., and Sexton P.M. Multiple amylin receptor phenotypes arise from RAMP interaction with the calcitonin receptor gene product. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 5 (1998) 37
50. Tilakaratne N., Christopoulos G., Zumpe E.T., Foord S.M., and Sexton P.M. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J. Pharmacol. Exp. Ther. 294 (2000) 61-72
51. van Rossum D., Menard D.P., Fournier A., St Pierre S., and Quirion R. Autoradiographic distribution and receptor binding profile of [I-125]Bolton Hunter-rat amylin binding sites in the rat brain. J. Pharmacol. Exp. Ther. 270 (1994) 779-787
52. Vine W., Beaumont K., Gedulin B., Pittner R., Moore C.X., Rink T.J., and Young A.A. Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats. Eur. J. Pharmacol. 314 (1996) 115-121
53. Wang M.W., Young A.A., Rink T.J., and Cooper G.J.S. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett. 291 (1991) 195-198
54. Wookey P., Tikellis C., Du C., Sexton P., Young A.A., Gaeta L.S.L., Prickett K.S., Beaumont K., and Cooper M.E. Identification, characterisation and localisation of amylin binding sites in rat kidney using specific amylin antagonists. J. Hypertension 12 (1994) S9
55. Wookey P.J., Tikellis C., Du H.C., Qin H.F., Sexton P.M., and Cooper M.E. Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin. Am. J. Physiol. 39 (1996) F289-F294
56. Wookey P.J., Cao Z., vanGeenen R.C.I., Voskuil M., Darby I.A., Komers R., and Cooper M.E. Increased density of renal amylin binding sites in experimental hypertension. Hypertension 30 (1997) 455-460
57. Young A., Moore C., Herich J., and Beaumont K. Neuroendocrine actions of amylin. In: Poyner D., Marshall I., and Brain S.D. (Eds). "The CGRP Family: Calcitonin Gene-Related Peptide (CGRP), Amylin, and Adrenomedullin" (2000), Landes Bioscience, Georgetown, TX 91-102
58. Young A.A., Carlo P., Rink T.J., and Wang M.-W. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol. Cell Endocrinol. 84 (1992) R1-R5
59. Young A.A., Gedulin B., Gaeta L.S.L., Prickett K.S., Beaumont K., Larson E., and Rink T.J. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat-Evidence for a metabolic role of endogenous amylin. FEBS Lett. 343 (1994) 237-241
60. Zaidi M., Alam A.S.M.T., Soncini R., Avaldi F., and Moonga B.S. Calcitonin acts upon two receptor subtypes on the osteoclast: The 'amylin-site' and the 'calcitonin-site'. J. Bone Miner. Res. 6 (1991) S198
61. Zimmermann U., Fluehmann B., Born W., Fischer J.A., and Muff R. Coexistence of novel amylin-binding sites with calcitonin receptors in human breast carcinoma MCF-7 cells. J. Endocrinol. 155 (1997) 423-431
62. Zumpe E.T., Tilakaratne N., Fraser N.J., Christopoulos G., Foord S.M., and Sexton P.M. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. Biochem. Biophys. Res. Commun. 267 (2000) 368-372